{"transactions":[{"id":1851772,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T17:40:44.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":245400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":245400,"derivative":{"exercise_price":38.74,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":245400},"source":{"system":"sec-edgar","filing":"0001209191-23-038031","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919123038031/doc4.xml","form_type":"4"}},{"id":1851771,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2023-06-16T17:40:44.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":32700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2024, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":186481,"source":{"system":"sec-edgar","filing":"0001209191-23-038031","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919123038031/doc4.xml","form_type":"4"}},{"id":1863665,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2023-06-07T21:33:34.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":5326,"price":37.865,"value":201668.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":153781,"source":{"system":"sec-edgar","filing":"0001209191-23-035264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919123035264/doc4.xml","form_type":"4"}},{"id":1863664,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2023-06-07T21:33:34.000Z","date":"2023-06-06","kind":"sale","planned":false,"acquired":false,"shares":5058,"price":38.991,"value":197216.478,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 414 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022 and December 2022."}],"balance_after":159107,"source":{"system":"sec-edgar","filing":"0001209191-23-035264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919123035264/doc4.xml","form_type":"4"}},{"id":2238878,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-08T19:51:00.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":160900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":160900,"derivative":{"exercise_price":59.39,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":160900},"source":{"system":"sec-edgar","filing":"0001209191-22-035235","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919122035235/doc4.xml","form_type":"4"}},{"id":2238877,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-06-08T19:51:00.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":163751,"source":{"system":"sec-edgar","filing":"0001209191-22-035235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919122035235/doc4.xml","form_type":"4"}},{"id":2238876,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-06-08T19:51:00.000Z","date":"2022-06-08","kind":"sale","acquired":false,"shares":501,"price":61.96,"value":31041.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.89 to $62.24, inclusive."}],"balance_after":142251,"source":{"system":"sec-edgar","filing":"0001209191-22-035235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919122035235/doc4.xml","form_type":"4"}},{"id":2238875,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-06-08T19:51:00.000Z","date":"2022-06-08","kind":"sale","acquired":false,"shares":1282,"price":61.31,"value":78599.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.840 to $61.825, inclusive."}],"balance_after":142752,"source":{"system":"sec-edgar","filing":"0001209191-22-035235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919122035235/doc4.xml","form_type":"4"}},{"id":2238874,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-06-08T19:51:00.000Z","date":"2022-06-08","kind":"sale","acquired":false,"shares":5006,"price":60.33,"value":302011.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.83 to $60.82, inclusive."}],"balance_after":144034,"source":{"system":"sec-edgar","filing":"0001209191-22-035235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919122035235/doc4.xml","form_type":"4"}},{"id":2238873,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-06-08T19:51:00.000Z","date":"2022-06-08","kind":"sale","acquired":false,"shares":7039,"price":59.1,"value":416004.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.79 to $59.73, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 6."}],"balance_after":149040,"source":{"system":"sec-edgar","filing":"0001209191-22-035235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919122035235/doc4.xml","form_type":"4"}},{"id":2238872,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-06-08T19:51:00.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":11965,"price":61.374,"value":734339.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":156079,"source":{"system":"sec-edgar","filing":"0001209191-22-035235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919122035235/doc4.xml","form_type":"4"}},{"id":2286311,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-02T18:34:31.000Z","date":"2022-04-28","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":0,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-22-026483","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919122026483/doc4.xml","form_type":"4"}},{"id":2286310,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-05-02T18:34:31.000Z","date":"2022-04-28","kind":"exercise","acquired":true,"shares":22500,"price":10.81,"value":243225.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":168044,"source":{"system":"sec-edgar","filing":"0001209191-22-026483","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919122026483/doc4.xml","form_type":"4"}},{"id":2303869,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-05T17:26:11.000Z","date":"2022-03-31","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":22500,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-22-023190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919122023190/doc4.xml","form_type":"4"}},{"id":2303868,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-04-05T17:26:11.000Z","date":"2022-03-31","kind":"exercise","acquired":true,"shares":22500,"price":10.81,"value":243225.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":145544,"source":{"system":"sec-edgar","filing":"0001209191-22-023190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919122023190/doc4.xml","form_type":"4"}},{"id":2423878,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-27T16:27:40.000Z","date":"2022-01-25","kind":"exercise","acquired":false,"shares":13670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":45000,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":13670},"source":{"system":"sec-edgar","filing":"0001209191-22-005202","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919122005202/doc4.xml","form_type":"4"}},{"id":2423877,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-01-27T16:27:40.000Z","date":"2022-01-25","kind":"exercise","acquired":true,"shares":13670,"price":10.81,"value":147772.7,"ownership":{"direct":true},"balance_after":123044,"source":{"system":"sec-edgar","filing":"0001209191-22-005202","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919122005202/doc4.xml","form_type":"4"}},{"id":2435774,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-13T16:11:37.000Z","date":"2022-01-11","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":58670,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-003176","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919122003176/doc4.xml","form_type":"4"}},{"id":2435773,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2022-01-13T16:11:37.000Z","date":"2022-01-11","kind":"exercise","acquired":true,"shares":15000,"price":10.81,"value":162150.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 289 shares of common stock acquired under the issuer's employee stock purchase plan in December 2021."}],"balance_after":109374,"source":{"system":"sec-edgar","filing":"0001209191-22-003176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919122003176/doc4.xml","form_type":"4"}},{"id":2504550,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-18T16:22:06.000Z","date":"2021-11-16","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":73670,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-065463","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121065463/doc4.xml","form_type":"4"}},{"id":2504549,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-11-18T16:22:06.000Z","date":"2021-11-16","kind":"exercise","acquired":true,"shares":15000,"price":10.81,"value":162150.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 129 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021."}],"balance_after":94085,"source":{"system":"sec-edgar","filing":"0001209191-21-065463","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121065463/doc4.xml","form_type":"4"}},{"id":2612773,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:51:50.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":5.81,"underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-21-050036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121050036/doc4.xml","form_type":"4"}},{"id":2612772,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:51:50.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":7.98,"underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-21-050036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121050036/doc4.xml","form_type":"4"}},{"id":2612771,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:51:50.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":1.45,"underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-21-050036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121050036/doc4.xml","form_type":"4"}},{"id":2612770,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:51:50.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":1.35,"underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-21-050036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121050036/doc4.xml","form_type":"4"}},{"id":2612769,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:51:50.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":3.14,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-050036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121050036/doc4.xml","form_type":"4"}},{"id":2612768,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:51:50.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":72683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":5.57,"underlying":"Common Stock","underlying_shares":72683},"source":{"system":"sec-edgar","filing":"0001209191-21-050036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121050036/doc4.xml","form_type":"4"}},{"id":2612767,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:51:50.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":91954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each option to purchase Shares (each, a \"Company Option\") that was outstanding and unexercised prior to the Effective Time, whether or not vested, by virtue of the Merger, ceased to represent a right to acquire Shares and was converted into the option to purchase Parent ADSs  (each an \"Assumed Stock Option\"). The number of Parent ADSs shall be equal to (i) number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":3.29,"underlying":"Common Stock","underlying_shares":91954},"source":{"system":"sec-edgar","filing":"0001209191-21-050036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121050036/doc4.xml","form_type":"4"}},{"id":2612766,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T17:51:50.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each share of common stock of the Company (each, a \"Share\") (excluding any Shares held in the treasury of the Company or owned, directly or indirectly, by Parent or Merger Sub immediately prior to the Effective Time) was cancelled and converted into the right to receive 0.396 (the \"Exchange Ratio\") American Depositary Shares of Parent (\"Parent ADS\") representing five ordinary shares of Parent."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"At the Effective Time, each share of common stock of the Company (each, a \"Share\") (excluding any Shares held in the treasury of the Company or owned, directly or indirectly, by Parent or Merger Sub immediately prior to the Effective Time) was cancelled and converted into the right to receive 0.396 (the \"Exchange Ratio\") American Depositary Shares of Parent (\"Parent ADS\") representing five ordinary shares of Parent."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Three Colleens Investment LLC, a limited liability company jointly owned and managed by the Reporting Person and his spouse. This Form 4 shall not be deemed an admission of beneficial ownership of these shares by the Reporting Person except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-050036","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121050036/doc4.xml","form_type":"4"}},{"id":2667060,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-17T00:05:56.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 14, 2021, the Reporting Person was granted 36,000 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of June 14, 2021 or (ii) the Issuer's annual general meeting of shareholders in such year."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":36000,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001562180-21-004328","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000156218021004328/primarydocument.xml","form_type":"4"}},{"id":2667059,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T00:05:56.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":45953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 14, 2021, the Reporting Person was granted an option to purchase 45,953 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the \"Plan\"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of June 14, 2021 or (ii) the Issuer's annual general meeting of shareholders in 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":45953,"derivative":{"exercise_price":5,"expiration_date":"2031-06-14","underlying":"Ordinary Shares","underlying_shares":45953},"source":{"system":"sec-edgar","filing":"0001562180-21-004328","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000156218021004328/primarydocument.xml","form_type":"4"}},{"id":2671580,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-11T20:38:41.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":133400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":133400,"derivative":{"exercise_price":60.96,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":133400},"source":{"system":"sec-edgar","filing":"0001209191-21-040091","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121040091/doc4.xml","form_type":"4"}},{"id":2671579,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-06-11T20:38:41.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":17800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":78956,"source":{"system":"sec-edgar","filing":"0001209191-21-040091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121040091/doc4.xml","form_type":"4"}},{"id":2677205,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-06-08T16:18:49.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":14905,"price":61.037,"value":909756.485,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":61156,"source":{"system":"sec-edgar","filing":"0001209191-21-038897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121038897/doc4.xml","form_type":"4"}},{"id":2679988,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-06-08T01:53:32.000Z","date":"2021-06-04","kind":"purchase","acquired":true,"shares":10000,"price":4.535,"value":45350.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.46 to $4.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Please see the section title \"Remarks\" below for additional information."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Three Colleens Investment LLC, a limited liability company jointly owned and managed by the Reporting Person and his spouse. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0000899243-21-022406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000089924321022406/doc4.xml","form_type":"4"}},{"id":2679987,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-06-08T01:53:32.000Z","date":"2021-06-03","kind":"purchase","acquired":true,"shares":5000,"price":4.623,"value":23115.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.61 to $4.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Please see the section title \"Remarks\" below for additional information."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Three Colleens Investment LLC, a limited liability company jointly owned and managed by the Reporting Person and his spouse. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0000899243-21-022406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000089924321022406/doc4.xml","form_type":"4"}},{"id":2714187,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-13T18:01:59.000Z","date":"2021-05-12","kind":"exercise","acquired":false,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":88670,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":21250},"source":{"system":"sec-edgar","filing":"0001209191-21-032424","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121032424/doc4.xml","form_type":"4"}},{"id":2714186,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-13T18:01:59.000Z","date":"2021-05-11","kind":"exercise","acquired":false,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":109920,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":21250},"source":{"system":"sec-edgar","filing":"0001209191-21-032424","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121032424/doc4.xml","form_type":"4"}},{"id":2714185,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-05-13T18:01:59.000Z","date":"2021-05-12","kind":"sale","acquired":false,"shares":3611,"price":62.41,"value":225362.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.355 to $62.595, inclusive."}],"balance_after":76061,"source":{"system":"sec-edgar","filing":"0001209191-21-032424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121032424/doc4.xml","form_type":"4"}},{"id":2714184,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-05-13T18:01:59.000Z","date":"2021-05-12","kind":"sale","acquired":false,"shares":14669,"price":62.08,"value":910651.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.355 to $62.35, inclusive."}],"balance_after":79672,"source":{"system":"sec-edgar","filing":"0001209191-21-032424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121032424/doc4.xml","form_type":"4"}},{"id":2714183,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-05-13T18:01:59.000Z","date":"2021-05-12","kind":"sale","acquired":false,"shares":2970,"price":60.76,"value":180457.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.33 to $61.31, inclusive."}],"balance_after":94341,"source":{"system":"sec-edgar","filing":"0001209191-21-032424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121032424/doc4.xml","form_type":"4"}},{"id":2714182,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-05-13T18:01:59.000Z","date":"2021-05-12","kind":"exercise","acquired":true,"shares":21250,"price":10.81,"value":229712.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":97311,"source":{"system":"sec-edgar","filing":"0001209191-21-032424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121032424/doc4.xml","form_type":"4"}},{"id":2714181,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-05-13T18:01:59.000Z","date":"2021-05-11","kind":"sale","acquired":false,"shares":7932,"price":61.19,"value":485359.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.68, inclusive."}],"balance_after":76061,"source":{"system":"sec-edgar","filing":"0001209191-21-032424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121032424/doc4.xml","form_type":"4"}},{"id":2714180,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-05-13T18:01:59.000Z","date":"2021-05-11","kind":"sale","acquired":false,"shares":13318,"price":60.78,"value":809468.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.995, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 7."}],"balance_after":83993,"source":{"system":"sec-edgar","filing":"0001209191-21-032424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121032424/doc4.xml","form_type":"4"}},{"id":2714179,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-05-13T18:01:59.000Z","date":"2021-05-11","kind":"exercise","acquired":true,"shares":21250,"price":10.81,"value":229712.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":97311,"source":{"system":"sec-edgar","filing":"0001209191-21-032424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121032424/doc4.xml","form_type":"4"}},{"id":2714178,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-05-13T18:01:59.000Z","date":"2021-03-24","kind":"gift","acquired":false,"shares":1080,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Three Colleens Investment, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP."}],"balance_after":97273,"source":{"system":"sec-edgar","filing":"0001209191-21-032424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121032424/doc4.xml","form_type":"4"}},{"id":2878992,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-04T19:58:03.000Z","date":"2021-02-03","kind":"exercise","acquired":false,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":131170,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":21250},"source":{"system":"sec-edgar","filing":"0001209191-21-007906","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121007906/doc4.xml","form_type":"4"}},{"id":2878991,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-04T19:58:03.000Z","date":"2021-02-02","kind":"exercise","acquired":false,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":152420,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":21250},"source":{"system":"sec-edgar","filing":"0001209191-21-007906","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121007906/doc4.xml","form_type":"4"}},{"id":2878990,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-02-04T19:58:03.000Z","date":"2021-02-03","kind":"sale","acquired":false,"shares":14350,"price":71.42,"value":1024877.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.99 to $71.85, inclusive."}],"balance_after":76061,"source":{"system":"sec-edgar","filing":"0001209191-21-007906","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121007906/doc4.xml","form_type":"4"}},{"id":2878989,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-02-04T19:58:03.000Z","date":"2021-02-03","kind":"sale","acquired":false,"shares":6900,"price":70.78,"value":488382.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.99 to $70.985, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the transfer of 98,353 shares of common stock previously held directly by the reporting person to Three Colleens Investment, LLC, an entity through which the reporting person holds such shares of common stock indirectly."}],"balance_after":90411,"source":{"system":"sec-edgar","filing":"0001209191-21-007906","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121007906/doc4.xml","form_type":"4"}},{"id":2878988,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-02-04T19:58:03.000Z","date":"2021-02-03","kind":"exercise","acquired":true,"shares":21250,"price":10.81,"value":229712.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":97311,"source":{"system":"sec-edgar","filing":"0001209191-21-007906","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121007906/doc4.xml","form_type":"4"}},{"id":2878987,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-02-04T19:58:03.000Z","date":"2021-02-02","kind":"sale","acquired":false,"shares":4100,"price":70.2,"value":287820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.83 to $70.795, inclusive."}],"balance_after":76061,"source":{"system":"sec-edgar","filing":"0001209191-21-007906","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121007906/doc4.xml","form_type":"4"}},{"id":2878986,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-02-04T19:58:03.000Z","date":"2021-02-02","kind":"sale","acquired":false,"shares":14250,"price":69.38,"value":988665.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.83 to $69.815, inclusive."}],"balance_after":80161,"source":{"system":"sec-edgar","filing":"0001209191-21-007906","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121007906/doc4.xml","form_type":"4"}},{"id":2878985,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-02-04T19:58:03.000Z","date":"2021-02-02","kind":"sale","acquired":false,"shares":2900,"price":68.41,"value":198389.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.83 to $68.82, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 through 8."}],"balance_after":94411,"source":{"system":"sec-edgar","filing":"0001209191-21-007906","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121007906/doc4.xml","form_type":"4"}},{"id":2878984,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-02-04T19:58:03.000Z","date":"2021-02-02","kind":"exercise","acquired":true,"shares":21250,"price":10.81,"value":229712.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 144 shares of common stock acquired under the issuer's employee stock purchase plan in December 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the transfer of 98,353 shares of common stock previously held directly by the reporting person to Three Colleens Investment, LLC, an entity through which the reporting person holds such shares of common stock indirectly."}],"balance_after":97311,"source":{"system":"sec-edgar","filing":"0001209191-21-007906","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919121007906/doc4.xml","form_type":"4"}},{"id":2961740,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-12-03T01:05:10.000Z","date":"2020-11-30","kind":"purchase","acquired":true,"shares":25000,"price":4.8607,"value":121517.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.62 to $4.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Please see the section title \"Remarks\" below for additional information."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Three Colleens Investment LLC, a limited liability company jointly owned and managed by the Reporting Person and his spouse. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-20-061329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000120919120061329/doc4.xml","form_type":"4"}},{"id":2962562,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-01T19:40:40.000Z","date":"2020-11-30","kind":"purchase","acquired":true,"shares":25000,"price":4.2743,"value":106857.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.25 to $4.30, inclusive. The reporting person undertakes to provide to Chiasma, Inc., any security holder of Chiasma, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Three Colleens Investment LLC, a limited liability company jointly owned and managed by the Reporting Person and his spouse. This Form 4 shall not be deemed an admission of beneficial ownership of these shares by the Reporting Person except to the extent of his pecuniary interest therein."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-20-060980","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120060980/doc4.xml","form_type":"4"}},{"id":3005020,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-16T16:26:41.000Z","date":"2020-10-16","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":173670,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-055054","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120055054/doc4.xml","form_type":"4"}},{"id":3005019,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-16T16:26:41.000Z","date":"2020-10-15","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":203670,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-055054","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120055054/doc4.xml","form_type":"4"}},{"id":3005018,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-16T16:26:41.000Z","date":"2020-10-14","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects the transfer of stock options to purchase 243,129 shares of common stock previously held indirectly by the reporting person through LCK Investment LLC to the reporting person directly."}],"balance_after":233670,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-055054","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120055054/doc4.xml","form_type":"4"}},{"id":3005017,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-10-16T16:26:41.000Z","date":"2020-10-16","kind":"sale","acquired":false,"shares":30000,"price":55.56,"value":1666800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":173377,"source":{"system":"sec-edgar","filing":"0001209191-20-055054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120055054/doc4.xml","form_type":"4"}},{"id":3005016,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-10-16T16:26:41.000Z","date":"2020-10-16","kind":"exercise","acquired":true,"shares":30000,"price":10.81,"value":324300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":203377,"source":{"system":"sec-edgar","filing":"0001209191-20-055054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120055054/doc4.xml","form_type":"4"}},{"id":3005015,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-10-16T16:26:41.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":30000,"price":55,"value":1650000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":173377,"source":{"system":"sec-edgar","filing":"0001209191-20-055054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120055054/doc4.xml","form_type":"4"}},{"id":3005014,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-10-16T16:26:41.000Z","date":"2020-10-15","kind":"exercise","acquired":true,"shares":30000,"price":10.81,"value":324300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":203377,"source":{"system":"sec-edgar","filing":"0001209191-20-055054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120055054/doc4.xml","form_type":"4"}},{"id":3005013,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-10-16T16:26:41.000Z","date":"2020-10-14","kind":"sale","acquired":false,"shares":30000,"price":55.53,"value":1665900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":173377,"source":{"system":"sec-edgar","filing":"0001209191-20-055054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120055054/doc4.xml","form_type":"4"}},{"id":3005012,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-10-16T16:26:41.000Z","date":"2020-10-14","kind":"exercise","acquired":true,"shares":30000,"price":10.81,"value":324300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":203377,"source":{"system":"sec-edgar","filing":"0001209191-20-055054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120055054/doc4.xml","form_type":"4"}},{"id":3052066,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-08-19T17:44:16.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":3217,"price":62.34,"value":200547.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.18 to $62.74, inclusive."}],"balance_after":173377,"source":{"system":"sec-edgar","filing":"0001209191-20-047576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120047576/doc4.xml","form_type":"4"}},{"id":3052065,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-08-19T17:44:16.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":11783,"price":61.79,"value":728071.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.18 to $62.17, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3."}],"balance_after":176594,"source":{"system":"sec-edgar","filing":"0001209191-20-047576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120047576/doc4.xml","form_type":"4"}},{"id":3080249,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-07-17T17:44:14.000Z","date":"2020-07-15","kind":"sale","acquired":false,"shares":12000,"price":56.88,"value":682560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 168 shares of common stock acquired under the issuer's employee stock purchase plan in June 2020."}],"balance_after":188377,"source":{"system":"sec-edgar","filing":"0001209191-20-042913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120042913/doc4.xml","form_type":"4"}},{"id":3082937,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-07-16T00:06:54.000Z","date":"2020-07-13","kind":"grant","acquired":true,"shares":27191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On July 13, 2020, the Reporting Person was granted 27,191 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of July 13, 2020 or (ii) the Issuer's annual general meeting of shareholders in such year."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":27191,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":27191},"source":{"system":"sec-edgar","filing":"0001562180-20-005125","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000156218020005125/primarydocument.xml","form_type":"4"}},{"id":3082936,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-16T00:06:54.000Z","date":"2020-07-13","kind":"grant","acquired":true,"shares":34805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 13, 2020, the Reporting Person was granted an option to purchase 34,805 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the \"Plan\"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of July 13, 2020 or (ii) the Issuer's annual general meeting of shareholders in 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":34805,"derivative":{"exercise_price":6.62,"expiration_date":"2030-07-13","underlying":"Ordinary Shares","underlying_shares":34805},"source":{"system":"sec-edgar","filing":"0001562180-20-005125","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000156218020005125/primarydocument.xml","form_type":"4"}},{"id":3111565,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-12T16:58:01.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Common Stock underlying the option will vest upon the earlier of (i) June 11, 2021 or the (ii) the date of the issuer's next annual meeting of the stockholders."}],"balance_after":13000,"derivative":{"exercise_price":5.81,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-20-036332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120036332/doc4.xml","form_type":"4"}},{"id":3113132,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T18:34:44.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":275000,"derivative":{"exercise_price":47.65,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001209191-20-036052","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120036052/doc4.xml","form_type":"4"}},{"id":3113131,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-06-11T18:34:44.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":33300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2021, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":200209,"source":{"system":"sec-edgar","filing":"0001209191-20-036052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120036052/doc4.xml","form_type":"4"}},{"id":3118371,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-06-08T21:09:20.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":1721,"price":48.49,"value":83451.29,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.435 to $48.65, inclusive."}],"balance_after":166909,"source":{"system":"sec-edgar","filing":"0001209191-20-035176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120035176/doc4.xml","form_type":"4"}},{"id":3118370,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-06-08T21:09:20.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":15390,"price":48.08,"value":739951.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.435 to $48.40, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3."}],"balance_after":168630,"source":{"system":"sec-edgar","filing":"0001209191-20-035176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120035176/doc4.xml","form_type":"4"}},{"id":3118369,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-06-08T21:09:20.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":14314,"price":46.331,"value":663181.934,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":184020,"source":{"system":"sec-edgar","filing":"0001209191-20-035176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120035176/doc4.xml","form_type":"4"}},{"id":3248756,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-25T16:55:24.000Z","date":"2020-02-21","kind":"exercise","acquired":false,"shares":16356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":0,"derivative":{"exercise_price":5.49,"expiration_date":"2020-12-29","underlying":"Common Stock","underlying_shares":16356},"source":{"system":"sec-edgar","filing":"0001209191-20-012555","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120012555/doc4.xml","form_type":"4"}},{"id":3248755,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-25T16:55:24.000Z","date":"2020-02-21","kind":"exercise","acquired":false,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 50% of the option shares on February 2, 2011, 19,377 option shares vested on February 3, 2011, and the remaining option shares vested in successive equal monthly installments for the subsequent 19 months."}],"balance_after":0,"derivative":{"exercise_price":1.61,"expiration_date":"2020-09-02","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001209191-20-012555","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120012555/doc4.xml","form_type":"4"}},{"id":3248754,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-02-25T16:55:24.000Z","date":"2020-02-21","kind":"exercise","acquired":true,"shares":16356,"price":5.49,"value":89794.44,"ownership":{"direct":true},"balance_after":198334,"source":{"system":"sec-edgar","filing":"0001209191-20-012555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120012555/doc4.xml","form_type":"4"}},{"id":3248753,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-02-25T16:55:24.000Z","date":"2020-02-21","kind":"exercise","acquired":true,"shares":19500,"price":1.61,"value":31395.0,"ownership":{"direct":true},"balance_after":181978,"source":{"system":"sec-edgar","filing":"0001209191-20-012555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120012555/doc4.xml","form_type":"4"}},{"id":3307575,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-17T18:13:05.000Z","date":"2020-01-15","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By LCK Investment LLC"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Reflects the transfer of stock options to purchase 20,541 shares of common stock previously held indirectly by the reporting person through LCK Investment LLC to the reporting person directly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC."}],"balance_after":243129,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-004148","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120004148/doc4.xml","form_type":"4"}},{"id":3307574,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-01-17T18:13:05.000Z","date":"2020-01-15","kind":"sale","acquired":false,"shares":1975,"price":43.48,"value":85873.0,"ownership":{"direct":false,"nature":"By LCK Investment LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.395 to $43.570, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC."}],"balance_after":1208,"source":{"system":"sec-edgar","filing":"0001209191-20-004148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120004148/doc4.xml","form_type":"4"}},{"id":3307573,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-01-17T18:13:05.000Z","date":"2020-01-15","kind":"sale","acquired":false,"shares":23025,"price":42.61,"value":981095.25,"ownership":{"direct":false,"nature":"By LCK Investment LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.340 to $43.330, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 and 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC."}],"balance_after":3183,"source":{"system":"sec-edgar","filing":"0001209191-20-004148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120004148/doc4.xml","form_type":"4"}},{"id":3307572,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2020-01-17T18:13:05.000Z","date":"2020-01-15","kind":"exercise","acquired":true,"shares":25000,"price":10.81,"value":270250.0,"ownership":{"direct":false,"nature":"By LCK Investment LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC."}],"balance_after":26208,"source":{"system":"sec-edgar","filing":"0001209191-20-004148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919120004148/doc4.xml","form_type":"4"}},{"id":3329638,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-30T16:05:32.000Z","date":"2019-12-26","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":16356,"derivative":{"exercise_price":5.49,"expiration_date":"2020-12-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-062104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919119062104/doc4.xml","form_type":"4"}},{"id":3329637,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-30T16:05:32.000Z","date":"2019-12-26","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 50% of the option shares on February 2, 2011, 19,377 option shares vested on February 3, 2011, and the remaining option shares vested in successive equal monthly installments for the subsequent 19 months."}],"balance_after":19500,"derivative":{"exercise_price":1.61,"expiration_date":"2020-09-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-062104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919119062104/doc4.xml","form_type":"4"}},{"id":3329636,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2019-12-30T16:05:32.000Z","date":"2019-12-26","kind":"exercise","acquired":true,"shares":10000,"price":5.49,"value":54900.0,"ownership":{"direct":true},"balance_after":162299,"source":{"system":"sec-edgar","filing":"0001209191-19-062104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919119062104/doc4.xml","form_type":"4"}},{"id":3329635,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2019-12-30T16:05:32.000Z","date":"2019-12-26","kind":"exercise","acquired":true,"shares":10000,"price":1.61,"value":16100.0,"ownership":{"direct":true},"balance_after":152299,"source":{"system":"sec-edgar","filing":"0001209191-19-062104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919119062104/doc4.xml","form_type":"4"}},{"id":3365624,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-19T16:16:36.000Z","date":"2019-11-15","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By LCK Investment LLC"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC."}],"balance_after":288670,"derivative":{"exercise_price":10.81,"expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-057149","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919119057149/doc4.xml","form_type":"4"}},{"id":3365623,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2019-11-19T16:16:36.000Z","date":"2019-11-15","kind":"sale","acquired":false,"shares":25000,"price":42.81,"value":1070250.0,"ownership":{"direct":false,"nature":"By LCK Investment LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.245 to $43.020, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC."}],"balance_after":1208,"source":{"system":"sec-edgar","filing":"0001209191-19-057149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919119057149/doc4.xml","form_type":"4"}},{"id":3365622,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2019-11-19T16:16:36.000Z","date":"2019-11-15","kind":"exercise","acquired":true,"shares":25000,"price":10.81,"value":270250.0,"ownership":{"direct":false,"nature":"By LCK Investment LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC."}],"balance_after":26208,"source":{"system":"sec-edgar","filing":"0001209191-19-057149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919119057149/doc4.xml","form_type":"4"}},{"id":3365621,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2019-11-19T16:16:36.000Z","date":"2019-11-15","kind":"sale","acquired":false,"shares":45000,"price":42.81,"value":1926450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.200 to $43.025, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 4."}],"balance_after":142299,"source":{"system":"sec-edgar","filing":"0001209191-19-057149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919119057149/doc4.xml","form_type":"4"}},{"id":3397224,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-04T16:31:30.000Z","date":"2019-10-02","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":26356,"derivative":{"exercise_price":549,"expiration_date":"2020-12-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-052556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919119052556/doc4.xml","form_type":"4"}},{"id":3397223,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-04T16:31:30.000Z","date":"2019-10-02","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 50% of the option shares on February 2, 2011, 19,377 option shares vested on February 3, 2011, and the remaining option shares vested in successive equal monthly installments for the subsequent 19 months."}],"balance_after":29500,"derivative":{"exercise_price":1.61,"expiration_date":"2020-09-02","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-19-052556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919119052556/doc4.xml","form_type":"4"}},{"id":3397222,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2019-10-04T16:31:30.000Z","date":"2019-10-02","kind":"exercise","acquired":true,"shares":10000,"price":5.49,"value":54900.0,"ownership":{"direct":true},"balance_after":187299,"source":{"system":"sec-edgar","filing":"0001209191-19-052556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919119052556/doc4.xml","form_type":"4"}},{"id":3397221,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2019-10-04T16:31:30.000Z","date":"2019-10-02","kind":"exercise","acquired":true,"shares":7000,"price":1.61,"value":11270.0,"ownership":{"direct":true},"balance_after":177299,"source":{"system":"sec-edgar","filing":"0001209191-19-052556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919119052556/doc4.xml","form_type":"4"}},{"id":3408911,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-20T17:13:52.000Z","date":"2019-09-18","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months."}],"balance_after":36356,"derivative":{"exercise_price":5.49,"expiration_date":"2020-12-29","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-19-050359","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919119050359/doc4.xml","form_type":"4"}},{"id":3408910,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-20T17:13:52.000Z","date":"2019-09-18","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 50% of the option shares on February 2, 2011, 19,377 option shares vested on February 3, 2011, and the remaining option shares vested in successive equal monthly installments for the subsequent 19 months."}],"balance_after":36500,"derivative":{"exercise_price":1.61,"expiration_date":"2020-09-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-19-050359","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919119050359/doc4.xml","form_type":"4"}},{"id":3408909,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112205,"kind":"person","name":"STACK DAVID M","position":1,"cik":"0001204788","reported_name":"STACK DAVID M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2019-09-20T17:13:52.000Z","date":"2019-09-18","kind":"exercise","acquired":true,"shares":6500,"price":5.49,"value":35685.0,"ownership":{"direct":true},"balance_after":170299,"source":{"system":"sec-edgar","filing":"0001209191-19-050359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204788/000120919119050359/doc4.xml","form_type":"4"}}],"next_cursor":"2019-09-20T17:13:52.000000Z,3408909"}